From April 28 to 30, 2026, Solopharm took part in the XV St. Petersburg Forum of Otorhinolaryngologists of Russia – one of the largest professional events in the field of otorhinolaryngology, traditionally held in St. Petersburg and bringing together leading specialists, researchers, practicing physicians, and representatives of the pharmaceutical industry.
The Forum serves as a significant platform for discussing modern approaches to the diagnosis, treatment, and prevention of ENT diseases, as well as for exchanging clinical experience and scientific developments.
Solopharm’s Participation: Scientific Dialogue and Professional Engagement
As part of the Forum, Solopharm presented the company at the exhibition area, operating a booth for the medical community.
At the booth, Solopharm specialists consulted physicians on the company’s products, answered professional questions, and introduced Forum participants to current solutions in the therapy of ENT diseases.
Special attention was given to interactive formats of audience engagement. The following activities were organized for Forum participants:
– A photo zone and photo booth featuring Angidak® branding as part of the promotion of Angidak® Intensiv.
– A tasting of Solosorb, allowing physicians to personally evaluate its taste profile and ease of use.
– A tasting of Ingasalin®, offering participants the opportunity to get acquainted with the product through hands-on user experience.
This format facilitated a more dynamic professional dialogue and increased participant engagement.
Scientific Program
Solopharm also took part in the Forum’s scientific program. Within the congress, three presentations were delivered with the participation of leading experts:
– Svetlana Alekseenko – «Practical Issues in the Treatment of Acute Otitis Media in Frequently ill Children»
– Elena Esaulenko – «Respiratory Viral Infection: The Role of Immunoadaptogens in Comprehensive Therapy and Prevention»
– Sergey Ryazantsev – «Combined Therapy of Acute Tonsillitis»
The presentations by Solopharm’s speakers generated considerable interest among the professional audience and attracted large numbers of attendees, confirming the relevance of the topics addressed and the demand for practice-oriented scientific content.
Comment from the Solopharm Press Center
For Solopharm, participating in professional medical forums is, above all, an opportunity to engage in open dialogue with the medical community, discuss real clinical needs, and present modern therapeutic approaches.
